Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Bioanalysis
|
July 11, 2020
Have we got 'patient-centric sampling' right?
Remco A Koster
Bioanalysis
|
October 1, 2019
Very complex internal standard response variation in LC-MS/MS bioanalysis: root cause analysis and impact assessment
Nico C van de Merbel, Remco A Koster, Corey Ohnmacht
Bioanalysis
|
June 5, 2018
Simple and robust LC-MS/MS analysis method for therapeutic drug monitoring of micafungin
Jasper M Boonstra, Erwin M Jongedijk, Remco A Koster, et al.
Bioanalysis
|
March 21, 2019
A volumetric absorptive microsampling LC-MS/MS method for five immunosuppressants and their hematocrit effects
Remco A Koster, Pascal Niemeijer, Herman Veenhof, et al.
Bioanalysis
|
October 22, 2014
Quantification of amikacin and kanamycin in serum using a simple and validated LC-MS/MS method
Jacob A Dijkstra, Marieke Gg Sturkenboom, Kai van Hateren, et al.
Bioanalysis
|
August 14, 2015
The relation of the number of hydrogen-bond acceptors with recoveries of immunosuppressants in DBS analysis
Remco A Koster, Jan-Willem C Alffenaar, Rixt Botma, et al.
Bioanalysis
|
March 10, 2015
Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples
Susan Hofman, Mathieu S Bolhuis, Remco A Koster, et al.
Bioanalysis
|
June 6, 2015
The performance of five different dried blood spot cards for the analysis of six immunosuppressants
Remco A Koster, Rixt Botma, Ben Greijdanus, et al.
Bioanalysis
|
February 21, 2015
What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?
Remco A Koster, Jan-Willem C Alffenaar, Rixt Botma, et al.
Bioanalysis
|
March 17, 2017
Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS/MS systems
Remco A Koster, Herman Veenhof, Rixt Botma, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Bioanalysis
|
July 11, 2020
Have we got 'patient-centric sampling' right?
Remco A Koster
Bioanalysis
|
October 1, 2019
Very complex internal standard response variation in LC-MS/MS bioanalysis: root cause analysis and impact assessment
Nico C van de Merbel, Remco A Koster, Corey Ohnmacht
Bioanalysis
|
June 5, 2018
Simple and robust LC-MS/MS analysis method for therapeutic drug monitoring of micafungin
Jasper M Boonstra, Erwin M Jongedijk, Remco A Koster, et al.
Bioanalysis
|
March 21, 2019
A volumetric absorptive microsampling LC-MS/MS method for five immunosuppressants and their hematocrit effects
Remco A Koster, Pascal Niemeijer, Herman Veenhof, et al.
Bioanalysis
|
October 22, 2014
Quantification of amikacin and kanamycin in serum using a simple and validated LC-MS/MS method
Jacob A Dijkstra, Marieke Gg Sturkenboom, Kai van Hateren, et al.
Bioanalysis
|
August 14, 2015
The relation of the number of hydrogen-bond acceptors with recoveries of immunosuppressants in DBS analysis
Remco A Koster, Jan-Willem C Alffenaar, Rixt Botma, et al.
Bioanalysis
|
March 10, 2015
Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples
Susan Hofman, Mathieu S Bolhuis, Remco A Koster, et al.
Bioanalysis
|
June 6, 2015
The performance of five different dried blood spot cards for the analysis of six immunosuppressants
Remco A Koster, Rixt Botma, Ben Greijdanus, et al.
Bioanalysis
|
February 21, 2015
What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?
Remco A Koster, Jan-Willem C Alffenaar, Rixt Botma, et al.
Bioanalysis
|
March 17, 2017
Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS/MS systems
Remco A Koster, Herman Veenhof, Rixt Botma, et al.
Page
of 2